Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Otolaryngologic Clinics of North AmericaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Concerning the nature of intolerance to aspirin.J Allergy. 1967; 40: 281-293
- Intolerance to aspirin. Clinical studies and consideration of its pathogenesis.Ann Intern Med. 1968; 68: 975-983
- NSAID-ERD Syndrome: the new hope from prevention, early diagnosis and new therapeutic targets.Curr Allergy Asthma Rep. 2020; 20: 10
- Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin exacerbated respiratory disease.J Allergy Clin Immunol. 2017; 5: 1061-1070
- Aspirin-exacerbated respiratory disease: longitudinal assessment of a large cohort and implications of diagnostic delay.Int Forum Allergy Rhinol. 2019; 10: 465-473
- Clinical and pathologic perspectives on aspirin sensitivity and asthma.J Allergy Clin Immunol. 2006; 118: 773-786
- Aspirin-exacerbated respiratory disease.N Engl J Med. 2018; 379: 1060-1070
- Natural history of aspirin-induced asthma. AIANE Investigators. European network on aspirin-induced asthma.Eur Resp J. 2000; 16: 432-436
- Demographic variation in chronic rhinosinusitis by subtype and region: a systematic review.Am J Rhinol Allergy. 2022; 36: 367-377
- Longitudinal progression of aspirin-exacerbated respiratory disease: analysis of a national insurance claims database.Int Forum Allergy Rhinol. 2019; 9: 1420-1423
- The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety.World J Otorhinolaryngol. 2020; 6: 203-206
- Aspirin-exacerbated respiratory disease: A review.Laryngoscope Investig Otolaryngol. 2020; 5: 360-367
- Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2021; 148: 283-291
- Olfaction and sino-nasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study.Eur Arch Ororhinolaryngol. 2017; 274: 1487-1493
- A one-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2019; 7: 1174-1180
- Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2019; 143 (e792): 799-803
- ASA challenge in children with hypersensitivity reactions to NSAIDs differentiate between cross-intolerant and selective responders.J Allergy Clin Immunol Pract. 2018; 6: 1226-1232
- Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) -- a EAACI position paper.Allergy. 2019; 74: 28-39
- Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease.J Allergy Clin Immunol Pract. 2014; 2: 208-213
- Diagnosis of asthma: diagnostic testing.Int Forum Allergy Rhinol. 2015; 5: S27-S30
- International consensus statement on allergy and rhinology: rhinosinusitis 2021.Int Forum Allergy Rhinol. 2021; 11: 213-739
- A comparison of sphenoid sinus osteoneogenesis in aspirin-exacerbated respiratory disease.Am J Rhinol Allergy. 2021; 35: 172-178
- Aspirin hypersensitivity: characteristics and diagnostic approach [in French].Rev Mal Respir. 2015; 32: 221-228
- The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease.Allergy Asthma Proc. 2013; 34: 378-382
- The role of aspirin desensitization followed by oral aspirin therapy in managging patients with aspirin-exacerbated respiratory disease: a work group report from the rhinitis, rhinosinusitis and ocular allergy committee of the American Academy of Allergy, Asthma & Immunology.J Allergy Clin Immunol. 2021; 147: 827-844
- Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2021; 148: 344-347
- Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease.Ann Allergy Asthma Immunol. 2006; 97: 190-195
- Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management.Med Sci. 2019; 7: 45
- Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: a single center study.J Allergy Clin Immunol. 2018; 141: 250-256
- Leukotriene-E(4) and granulocytic infiltration into asthmatic airways.Lancet. 1993; 341: 989-990
- Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses.J Allergy Clin Immunol. 1999; 104: 559-564
- Elevated urine leukotriene E4 is associated with worse objective markers in nasal polyposis patients.Laryngoscope. 2020; 131: 961-966
- Urine leukotriene E4: implications as a biomarker in chronic rhinosinusitis.Otolaryngol Head Neck Surg. 2022; 166: 224-232
- Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: a marker of systemic mastocytosis.Clin Biochem. 2016; 49: 979-982
- Diagnostic utility of urinary LTE4 in asthma, allergic rhinitis, chronic rhinosinusitis, nasal polyps, and aspirin sensitivity.J Allergy Clin Immunol. 2016; 4: 665-670
- Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.J Allergy Clin Immunol. 2004; 113: 277-283
- Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.Cancer Prev Res (Phila). 2015; 6: 646-655
- Symptom control of patients with chronic rhinosinusitis with nasal polyps under maintenance therapy with daily acetylsalicylic acid.Am J Rhinol Allergy. 2020; 34: 554-563
- Complete endoscopic sinus surgery followed by aspirin desensitization is associated with decreased overall corticosteroid use.Int Forum Allergy Rhinol. 2020; 10: 1043-1048
- Urinary leukotriene E4 to determine aspirin intolerance in asthma: a systematic review and meta-analysis.J Allergy Clin Immunol. 2016; 5: 990-997
- Leukotriene receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis.N Engl J Med. 2002; 347: 1493-1499
- Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2015; 135: 245-252
- Aspirin-exacerbated respiratory disease - new prime suspects.N Engl J Med. 2016; 374: 484-488
- Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations.Biochim Biophys Acta. 1992; 1128: 139-146
- Human platelets produce granulocyte-macrophage colony-stimulating factor and delay eosinophil apoptosis.Lab Investig. 2003; 83: 589-598
- Mass cytometry reveals unique subsets of T cells and lymphoid cells in nasal polyps from patients with chronic rhinosinusitis (CRS).Allergy. 2021; 76: 2222-2226
- Pre-intervention SNOT-22 scores predict outcomes in aspirin exacerbated respiratory disease.Am J Otolaryngol. 2021; 42: 103025
- Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis.World J Otorhinolaryngol. 2020; 6: 207-213
- Sinus surgery is associated with a decrease in aspirin-induced reaction severity in AERD patients.J Allergy Clin Immunol. 2019; 7: 1580-1588
- Endoscopic sinus surgery improves aspirin treatment response in AERD patients.Int Forum Allergy Rhinol. 2019; 9: 1401-1408
- The role of surgery in management of Samter's Triad: a systematic review.Otolaryngol Head Neck Surg. 2016; 155: 220-237
- Revision surgery rates in chronic rhinosinusitis with nasal polyps: a meta-analysis of risk factors.Int Forum Allergy Rhinol. 2020; 10: 199-207
- Outcomes of complete vs targeted approaches to endoscopic sinus surgery.Int Forum Allergy Rhinol. 2015; 5: 691-700
- Appropriate extent of surgery for aspirin-exacerbated respiratory disease.World J Otorhinolaryngol. 2020; 6: 235-240
- Surgical outcomes in aspirin-exacerbated respiratory disease without aspirin desensitization.Int Forum Allergy Rhinol. 2020; 10: 1149-1157
- Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches.Int Forum Allergy Rhinol. 2020; 10: 1035-1036
- Multidisciplinary single-center outcomes compared to two-center outcomes for the treatment of aspirin exacerbated respiratory disease.J Allergy Clin Immunol Pract. 2021; 9: 2498-2500
- Evolution of the endoscopic modified Lothrop procedure: A systematic review and meta-analysis.Laryngoscope. 2018; 128: 317-326
- Role of frontal sinus surgery in nasal polyp recurrence.Laryngoscope. 2013; 123: 36-41
- Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis.Int Forum Allergy Rhinol. 2016; 6: 820-825
- Equivalence in outcomes between Draf 2B vs Draf 3 frontal sinusotomy for refractory chronic frontal rhinosinusitis.Int Forum Allergy Rhinol. 2018; 8: 25-31
- The "Cross-court draf IIb" procedure for advanced nasal septum or frontal sinus pathology and nasal septum pathology.Laryngoscope. 2018; 128: 1527-1530
- Draf IIB with superior septectomy: finding the "middle ground.Int Forum Allergy Rhinol. 2019; 9: 281-285
- Aspirin desensitization therapy in aspirin-exacerbated respiratory disease: a review.Int Forum Allergy Rhinol. 2020; 10: 450-464
- A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial.Int Forum Allergy Rhinol. 2016; 6: 385-391
- Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin exacerbated respiratory disease: an evidence-based review with recommendations.Int Forum Allergy Rhinol. 2016; 6: 1273-1283
- Dietary fatty acid modification for the treatment of Aspirin-Exacerbated Respiratory Disease: a prospective pilot trial.J Allergy Clin Immunol Pract. 2018; 6: 825-831
- Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.J Allergy Clin Immunol. 2006; 117: 45-52
- Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.Am J Resp Crit Care Med. 2002; 165: 9-14
- Leukotriene-associated rash in aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2020; 8: 3170-3171
- Survey-defined patient experiences with aspirin-exacerbated respiratory disease.J Allergy Clin Immunol Pract. 2015; 3: 711-718
- Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.Am J Resp Crit Care Med. 1998; 147: 1187-1194
- Efficacy of zileuton in patients with asthma and history of aspirin sensitiity: a retrospective analysis of data from two phase 3 studies.J Allergy Clin Immunol. 2017; 139: 1
- Risk of psychiatric adverse events among montelukast users.J Allergy Clin Immunol Pract. 2021; 9 (e312): 385-393
- Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.Drug Saf. 2007; 30: 805-815
- Updates on treatment options in aspirin exacerbated respiratory disease.Curr Opin Allergy Clin Immunol. 2022; 22: 50-54
- Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.Allergy Asthma Proc. 2021; 42: 136-141
- Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease.World J Otorhinolaryngol. 2020; 6: 220-229
- An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.J Allergy Clin Immunol Pract. 2015; 3: 926-931
- Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.J Allergy Clin Immunol Pract. 2019; 7: 1319-1321
- Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: a prospective cohort study.Auris Nasus Larynx. 2019; 46: 526-532
- Age as a factor in treatment of aspirin-exacerbated respiratory disease: relationship to required aspirin maintenance dose after desensitization.Int Forum Allergy Rhinol. 2020; 10: 1180-1181
- Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma.Am Rev Respir Dis. 1989; 140: 148-153
- Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease.Int Forum Allergy Rhinol. 2018; 8: 49-53
- Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.Otolaryngol Head Neck Surg. 2014; 151: 575-581
- Meta-analysis exploring sinopulmonary outcomes on aspirin desensitization in aspirin-exacerbated respiratory disease.Otolaryngol Head Neck Surg. 2021; 164: 11-18
- Dupilumab improves alcohol tolerance in aspirin-exacerbated respiratory disease.Ann Allergy Asthma Immunol. 2021; 127: 379-381
- Aspirin desensitization for aspirin-exacerbated respiratory disease in the era of biologics: clinical perspective.Int Forum Allergy Rhinol. 2021; 11: 822-823
- Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2003; 111: 180-186
- Major complications of aspirin desensitization and maintenance therapy in aspirin-exacerbated respiratory disease.Int Forum Allergy Rhinol. 2021; 11: 115-119
- Outcomes of aspirin exacerbated respiratory disease in patients treated with aspirin desensitization and biologics.Int Forum Allergy Rhinol. 2021; 12: 306-309
- Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Ra in a real-world setting.J Allergy Clin Immunol. 2021; 9: 2910-2912
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.N Engl J Med. 2018; 378: 2486-2496
- The cytokine network in chronic obstructive pulmonary disease.Am J Respir Cell Mol Biol. 2009; 41: 631-638
- Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis.J Allergy Clin Immunol. 2022; 149: 1286-1295
- Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD.J Allergy Clin Immunol Pract. 2019; 7: 2462-2465
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.Lancet. 2019; 394: 1638-1650
- Appraisal of the real-world effectiveness of biologic therapies in aspirin-exacerbated respiratory disease.J Allergy Clin Immunol Pract. 2021; 10: 478-484
- Dupilumab as add-on therapy for chronic rhinosinusitis for nasal polyposis in aspirin exacerbated respiratory disease.Am J Rhinol Allergy. 2021; 35: 399-407
- Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.Ann Allergy Asthma Immunol. 2022; 128: 326-328
- Immunology-based recommendations for available and upcoming biologics in aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2021; 148: 348-350
- A retrospective analysis of mepolizumab in patients with aspirin-exacerbated respiratory disease.J Allergy Clin Immunol Pract. 2018; 6: 1045-1047
- Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2021; 148: 574-584
- Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Respir Med. 2021; 9: 1141-1153
- Biologic therapies versus surgical management for aspirin-exacerbated respiratory disease: a review of preliminary data, efficacy, and cost.World J Otorhinolaryngol. 2020; 6: 230-234
- Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2016; 137: 1585-1587
- Omalizumab for aspirin hypersensitivity and leukotriene overproduction in aspirin-exacerbated respiratory disease: a randomized controlled trial.Am J Resp Crit Care Med. 2020; 201: 1488-1498
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.J Allergy Clin Immunol. 2020; 146: 595-605
- Omalizumab-induced aspirin tolerance in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease patients is independent of atopic sensitization.J Allergy Clin Immunol. 2021; 10: 506-516
- Aspirin desensitization vs biologics for patients with aspirin-exacerbated respiratory disease.Ann Allergy Asthma Immunol. 2021; 126: 118-119
- Economic Evaluation of Dupilumab Versus Endoscopic Sinus Surgery for the Treatment of Chronic Rhinosinusitis With Nasal Polyps.Int Forum Allergy Rhinol. 2021; https://doi.org/10.1002/alr.22936
- Chronic rhinosinusitis severity is associated with need for asthma-related systemic corticosteroids.Rhinology. 2017; 55: 211-217
- Chronic rhinosinusitis exacerbations are differentially associated with lost productivity based on asthma status.Rhinology. 2018; 56: 323-329
- Chronic rhinosinusitis with nasal polyps and asthma.J Allergy Clin Immunol Pract. 2021; 9: 1133-1141
- Etiology of nasal polyps associated with aspirin-sensitive asthma.Rhinol Suppl. 1989; 8: 15-24
- Analysis of Comorbidities and Objective Parameters in Refractory Chronic Rhinosinusitis.Laryngoscope. 2013; 123: S1-S11
- Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease.J Respir Med. 2015; 109: 588-595
- Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis.Allergy. 2017; 72: 483-491
- Treatment of chronic rhinosinusitis and its effects on asthma.Eur Resp J. 2006; 28: 68-74
- Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis.Ann Otol Rhinol Laryngol. 1999; 108: 355-359
- Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial.Lancet. 2022; 10: 337-346
- Aspirin or Other Nonsteroidal Inflammatory Agent Exacerbated Asthma.J Allergy Clin Immunol Pract. 2014; 2: 653-657
- Patient Satisfaction and Efficiency Benefits of a Novel Multidisciplinary Rhinology and Allergy Clinic.Ann Otol Rhinol Laryngol. 2020; 129: 699-706
- Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.J Allergy Clin Immunol. 2014; 133: 98-103
- Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes.Blood. 2012; 119: 3790-3798
- A trial of P2Y12 receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2018; 143: 316-324
- Tezepelumab in Adults with Uncontrolled Asthma.N Engl J Med. 2017; 377: 936-946
- Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.N Engl J Med. 2021; 384: 1800-1809
- Effects of an anti-TSLP antibody on allergen-induced asthmatic responses.N Engl J Med. 2014; 370: 2102-2110
- Fevipiprant in CRSwNP and comorbid asthma: wrong target population or wrong PGD2 receptor?.J Allergy Clin Immunol. 2022; https://doi.org/10.1016/j.jaci.2022.03.001
Article info
Publication history
Published online: October 22, 2022
Footnotes
Conflicts of Interest: The authors declare no relevant conflicts of interest.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
